We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Zoetis Inc (ZTS) USD0.01

Sell:$169.14 Buy:$169.15 Change: $1.42 (0.84%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Sell:$169.14
Buy:$169.15
Change: $1.42 (0.84%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Sell:$169.14
Buy:$169.15
Change: $1.42 (0.84%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Zoetis Inc. is an animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. It has a diversified business, commercializing products across eight core species: dogs, cats and horses (companion animals) and cattle, swine, poultry, fish and sheep (livestock); and within seven major product categories: parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics and medicated feed additives. The Company operates through two segments: the United States and International. Within each of these segments, it offers a diversified product portfolio for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America, and its products are sold in more than 100 countries.

Contact details

Address:
10 Sylvan Way
PARSIPPANY
07054
United States
Telephone:
+1 (973) 8227000
Website:
https://www.zoetis.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ZTS
ISIN:
US98978V1035
Market cap:
$77.16 billion
Shares in issue:
457.87 million
Sector:
Pharmaceuticals
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Kristin Peck
    Chief Executive Officer, Director
  • Wetteny Joseph
    Chief Financial Officer, Executive Vice President
  • Roxanne Lagano
    Executive Vice President, Chief Human Resources Officer, Global Operations
  • Wafaa Mamilli
    Executive Vice President, Chief Digital and Technology Officer and Group President - China, Brazil and Precision Animal Health
  • Heidi Chen
    Executive Vice President, General Counsel, Corporate Secretary; Business Lead of Human Health Diagnostics
  • Nicholas Ashton
    Executive Vice President, President - Global Manufacturing and Supply
  • Jeannette Astorga
    Executive Vice President - Corporate Affairs, Communications, Chief Sustainability Officer
  • Ester Banque
    Executive Vice President, President- U.S. Operations
  • Jamie Brannan
    Executive Vice President and President, International Operations and Aquaculture
  • Rimma Driscoll
    Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.